Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Cancer Chemotherapy and Pharmacology
|
October 26, 2014
Pharmacokinetics of abiraterone in healthy Japanese men: dose-proportionality and effect of food timing
Kouichi Inoue, Akira Shishido, Nicole Vaccaro, et al.
The Journal of Molecular Diagnostics : JMD
|
November 1, 2005
A practical approach to the detection of prognostically significant genomic aberrations in multiple myeloma
Zhong Chen, Bonnie Issa, Shiang Huang, et al.
The Neurohospitalist
|
December 24, 2021
Clinical Problem-Solving: Lower Extremity Weakness & Paresthesia in an Immunocompromised Patient With a Complex Cancer History
Brian Stamm, Margaret Yu, Jennifer Adrissi, et al.
Journal of Natural Products
|
September 25, 2004
Isolation and characterization of five new tetrasaccharide glycosides from the roots of Ipomoea stans and their cytotoxic activity
Ismael León, Raúl G Enríquez, Dino Gnecco, et al.
Clinical Pharmacokinetics
|
August 22, 2019
Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects
Carlos Pérez-Ruixo, Jonás Samuel Pérez-Blanco, Caly Chien, et al.
Clinical Pharmacology in Drug Development
|
April 30, 2016
Impact on abiraterone pharmacokinetics and safety: Open-label drug-drug interaction studies with ketoconazole and rifampicin
Apexa Bernard, Nicole Vaccaro, Milin Acharya, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 23, 2024
A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Dushen Chetty, et al.
Journal of Clinical Pharmacology
|
December 31, 2013
Single-dose pharmacokinetic studies of abiraterone acetate in men with hepatic or renal impairment
Thomas Marbury, Eric Lawitz, Robert Stonerock, et al.
Asian Journal of Urology
|
December 22, 2017
A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia
Dingwei Ye, Yiran Huang, Fangjian Zhou, et al.
Journal of Neuro-Oncology
|
August 31, 2012
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme
Kenneth F Grossmann, Howard Colman, Wallace A Akerley, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Cancer Chemotherapy and Pharmacology
|
October 26, 2014
Pharmacokinetics of abiraterone in healthy Japanese men: dose-proportionality and effect of food timing
Kouichi Inoue, Akira Shishido, Nicole Vaccaro, et al.
The Journal of Molecular Diagnostics : JMD
|
November 1, 2005
A practical approach to the detection of prognostically significant genomic aberrations in multiple myeloma
Zhong Chen, Bonnie Issa, Shiang Huang, et al.
The Neurohospitalist
|
December 24, 2021
Clinical Problem-Solving: Lower Extremity Weakness & Paresthesia in an Immunocompromised Patient With a Complex Cancer History
Brian Stamm, Margaret Yu, Jennifer Adrissi, et al.
Journal of Natural Products
|
September 25, 2004
Isolation and characterization of five new tetrasaccharide glycosides from the roots of Ipomoea stans and their cytotoxic activity
Ismael León, Raúl G Enríquez, Dino Gnecco, et al.
Clinical Pharmacokinetics
|
August 22, 2019
Population Pharmacokinetics of Apalutamide and its Active Metabolite N-Desmethyl-Apalutamide in Healthy and Castration-Resistant Prostate Cancer Subjects
Carlos Pérez-Ruixo, Jonás Samuel Pérez-Blanco, Caly Chien, et al.
Clinical Pharmacology in Drug Development
|
April 30, 2016
Impact on abiraterone pharmacokinetics and safety: Open-label drug-drug interaction studies with ketoconazole and rifampicin
Apexa Bernard, Nicole Vaccaro, Milin Acharya, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 23, 2024
A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer
Neeta Pandit-Taskar, Joseph A O'Donoghue, Dushen Chetty, et al.
Journal of Clinical Pharmacology
|
December 31, 2013
Single-dose pharmacokinetic studies of abiraterone acetate in men with hepatic or renal impairment
Thomas Marbury, Eric Lawitz, Robert Stonerock, et al.
Asian Journal of Urology
|
December 22, 2017
A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia
Dingwei Ye, Yiran Huang, Fangjian Zhou, et al.
Journal of Neuro-Oncology
|
August 31, 2012
Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme
Kenneth F Grossmann, Howard Colman, Wallace A Akerley, et al.
Page
of 3